Cargando…

MiRNAs with prognostic significance in multiple myeloma: A systemic review and meta-analysis

BACKGROUND: Multiple myeloma (MM) is a clonal plasma cell malignancy associated with hypercalcemia, bone lesions, and renal failure. The prognostic significance of the mutation of miRNAs, one kind of small noncoding RNA molecules that can modulate gene expression, should be confirmed in non-Hodgkin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Peipei, Xia, Tian, Ling, Yipeng, Chen, Bing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	4800
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831428/ https://www.ncbi.nlm.nih.gov/pubmed/31415363 http://dx.doi.org/10.1097/MD.0000000000016711

Ejemplares similares

Prognostic Impact of Cytogenetic Abnormalities in Multiple Myeloma: A Retrospective Analysis of 229 Patients
por: Jian, Yuan, et al.
Publicado: (2016)

Prognostic miRNA classifiers in t cell acute lymphoblastic leukemia: Study protocol for a systematic review and meta-analysis of observational clinical studies
por: Sabarimurugan, Shanthi, et al.
Publicado: (2019)

Prognostic significance of latent membrane protein 1 expression in non-Hodgkin lymphoma: A meta-analysis
por: Li, Xiao-Mei, et al.
Publicado: (2017)

Huanglian Jiedu Decoction for treatment of multiple myeloma: A protocol for a systematic review and meta-analysis
por: An, Na, et al.
Publicado: (2020)

Efficacy and safety of daratumumab in the treatment of relapsed/refractory multiple myeloma: A meta-analysis of randomized controlled trials
por: Huang, Zeng-Yi, et al.
Publicado: (2023)

Bortezomib-based treatment for multiple myeloma patients with renal impairment: A systematic review and meta-analysis of observational studies
por: Zhu, Wanqiu, et al.
Publicado: (2016)

Case report: simultaneous occurrence of multiple myeloma and non-Hodgkin lymphoma treated by CAR T therapy
por: Li, Tongjuan, et al.
Publicado: (2020)

Risk of Early Mortality in Patients With Newly Diagnosed Multiple Myeloma
por: Hsu, Pei, et al.
Publicado: (2015)

Interleukin-6 gene-174 G/C promoter polymorphism is not associated with multiple myeloma susceptibility: evidence from meta-analysis: A systematic review and meta-analysis
por: Dong, Xiaohui, et al.
Publicado: (2021)

Bone marrow stromal cells derived exosomal miR-10a and miR-16 may be involved in progression of patients with multiple myeloma by regulating EPHA8 or IGF1R/CCND1
por: Peng, Ye, et al.
Publicado: (2021)

Prognostic significance of long non coding maternally expressed gene 3 in pediatric acute myeloid leukemia
por: Xue, Hongjuan, et al.
Publicado: (2021)

Acquired hemophagocytic lymphohistiocytosis as initial manifestation of multiple myeloma: A case report and literature review
por: Mendes, Fernanda Rodrigues, et al.
Publicado: (2020)

Synchronous diagnosis of anaplastic large cell lymphoma and multiple myeloma in a patient: A case report
por: Shi, Xiaofeng, et al.
Publicado: (2020)

Bioinformatics analysis of constructing a HCV-related hepatocellular carcinoma miRNA–mRNA regulation network
por: Hao, Rui, et al.
Publicado: (2021)

Treatment-related acute granulocyte–monocytic leukemia from multiple myeloma: A case report and literature review
por: Qian, Juan, et al.
Publicado: (2017)

Combined immune score predicts the prognosis of newly diagnosed multiple myeloma patients in the bortezomib-based therapy era
por: Wei, Min, et al.
Publicado: (2021)

Coexistence of nodal marginal zone B-cell lymphoma and multiple myeloma: A case report and literature review
por: Wang, Manzhi, et al.
Publicado: (2022)

Coexistence of primary mediastinal MALT lymphoma and multiple myeloma like POEMS syndrome: A case report and literature review
por: Yin, Shangjin, et al.
Publicado: (2023)

Bortezomib combined with lenalidomide as the first-line treatment for the rare synchronous occurrence of multiple myeloma and pulmonary adenocarcinoma: A case report
por: Zuo, Wenli, et al.
Publicado: (2017)

Prognostic significance of SET-NUP214 fusion gene in acute leukemia after allogeneic hematopoietic stem cell transplantation
por: Gao, Meng-Ge, et al.
Publicado: (2020)

Once-weekly bortezomib had similar effectiveness and lower thrombocytopenia occurrence compared with twice-weekly bortezomib regimen in treating patients with newly diagnosed multiple myeloma in China
por: Yao, Rongxin, et al.
Publicado: (2019)

Prognostic and Clinicopathological Value of Survivin in Diffuse Large B-cell Lymphoma: A Meta-Analysis
por: Zhang, Ya, et al.
Publicado: (2015)

Successful management of a complicated clinical crisis: A patient with left-sided endocarditis and secondary hemophagocytic lymphohistiocytosis: a rare case report and literature review
por: Xu, Peipei, et al.
Publicado: (2017)

Recombinant human thrombopoietin improves the efficacy of intermediate-dose cyclophosphamide plus granulocyte colony-stimulating factor in mobilizing peripheral blood stem cells in patients with multiple myeloma: A cohort study
por: Wang, Guorong, et al.
Publicado: (2017)

Prognostic role of pretreatment neutrophil-lymphocyte ratio in patients with diffuse large B-cell lymphoma treated with RCHOP
por: Wang, Jing, et al.
Publicado: (2016)

Microarray analysis of differentially expressed microRNAs in myelodysplastic syndromes
por: Wan, Chengyao, et al.
Publicado: (2020)

The impact of iron chelation therapy on patients with lower/intermediate IPSS MDS and the prognostic role of elevated serum ferritin in patients with MDS and AML: A meta-analysis
por: Yang, Yuan, et al.
Publicado: (2019)

Long-term immunosuppression and multiple transplants predispose systemic lupus erythematosus patients with cytopenias to hematologic malignancies
por: Lanjewar, Sonali, et al.
Publicado: (2021)

Association of systemic inflammatory and autoimmune manifestations with myelodysplastic syndromes: A systematic review and meta-analysis
por: Liang, Qian, et al.
Publicado: (2022)

The incidence and prognostic effect of Fms-like tyrosine kinase 3 gene internal tandem and nucleolar phosphoprotein 1 genes in acute myeloid leukaemia: A PRISMA-compliant systematic review and meta-analysis
por: Liu, Heping, et al.
Publicado: (2020)

Exosome miRNAs profiling in serum and prognostic evaluation in patients with multiple myeloma
por: Fang, Teng, et al.
Publicado: (2023)

Circulating miRNAs as diagnostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance
por: Li, Jia, et al.
Publicado: (2020)

Neutrophil/Lymphocyte Ratio, Lymphocyte/Monocyte Ratio, and Absolute Lymphocyte Count/Absolute Monocyte Count Prognostic Score in Diffuse Large B-Cell Lymphoma: Useful Prognostic Tools in the Rituximab Era
por: Ho, Ching-Liang, et al.
Publicado: (2015)

Higher red blood cell distribution width at diagnose is a simple negative prognostic factor in chronic phase-chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: A retrospective study
por: Mao, Xia-Li, et al.
Publicado: (2021)

Early stage Acute B lymphocytic leukemia presenting with symptoms of ankylosing spondylitis (AS): A case report
por: Liu, Wei, et al.
Publicado: (2020)

Clinical characteristics of angioimmunoblastic T-cell lymphoma in China and C-reactive protein as an independent prognostic factor
por: Li, Ying, et al.
Publicado: (2017)

Late-onset severe hepatic sinusoidal obstruction syndrome in an allogeneic stem cell transplant recipient: A case report
por: Sun, Yan-ling, et al.
Publicado: (2020)

Clinical Outcomes for Systemic Corticosteroids Versus Vincristine in Treating Kaposiform Hemangioendothelioma and Tufted Angioma
por: Liu, Xiaohan, et al.
Publicado: (2016)

Exosomal miRNAs in the Tumor Microenvironment of Multiple Myeloma
por: Alipoor, Shamila D., et al.
Publicado: (2023)

The prevalence, risk factors, and prognostic value of anxiety and depression in refractory or relapsed acute myeloid leukemia patients of North China
por: Gu, Mianmian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9gjvv6ibea3couq3d3tko70u77